FCGR2A and autoimmune thrombocytopenic purpura: FCGR genes are reported to promote macrophage phagocytosis and platelet clearance in patients with immune thrombocytopenia and blocking FC receptors demonstrated to be an effective treatment strategy (45, 46, 48, 49).